Palantir Technologies Inc.
For the period ended Dec 31, 2025. Filed Feb 17, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 17, 2026
PLTR$168.82-0.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
| Years Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Operating activities | |||
| Net income | $1,634,644 | $467,918 | $217,375 |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Depreciation and amortization | 26,145 | 31,587 | 33,354 |
| Stock-based compensation | 684,033 | 691,638 | 475,903 |
| Unrealized and realized (gain) loss from marketable securities, net | 21,228 | 19,306 | 13,160 |
| Noncash consideration | (37,244) | (52,521) | (46,609) |
| Other operating activities | 15,630 | 66,034 | 12,764 |
| Changes in operating assets and liabilities: | |||
| Accounts receivable, net | (450,429) | (211,157) | (106,159) |
| Prepaid expenses and other assets | 51,979 | 11,883 | (2,955) |
| Accounts payable and accrued liabilities | 4,659 | 96,793 | 21,063 |
| Contract liabilities | 238,688 | 76,796 | 143,859 |
| Other liabilities | (54,860) | (44,412) | (49,572) |
| Net cash provided by operating activities | 2,134,473 | 1,153,865 | 712,183 |
| Investing activities | |||
| Purchases of property and equipment | (33,882) | (12,634) | (15,114) |
| Purchases of marketable securities | (7,702,060) | (5,395,913) | (5,636,406) |
| Proceeds from sales and redemption of marketable securities | 5,026,315 | 5,073,507 | 2,889,268 |
| Purchases of privately-held securities | (72,924) | (5,615) | — |
| Other investing activities | (1,000) | — | 51,072 |
| Net cash used in investing activities | (2,783,551) | (340,655) | (2,711,180) |
| Financing activities | |||
| Proceeds from the exercise of common stock options | 129,107 | 745,396 | 218,238 |
| Repurchases of common stock | (74,985) | (64,196) | — |
| Taxes paid related to net share settlement of equity awards | (81,117) | (218,280) | — |
| Other financing activities | 85 | 444 | 601 |
| Net cash provided by (used in) financing activities | (26,910) | 463,364 | 218,839 |
| Effect of foreign exchange on cash, cash equivalents, and restricted cash | 7,477 | (6,745) | 2,930 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | (668,511) | 1,269,829 | (1,777,228) |
| Cash, cash equivalents, and restricted cash - beginning of period | 2,119,936 | 850,107 | 2,627,335 |
| Cash, cash equivalents, and restricted cash - end of period | $1,451,425 | $2,119,936 | $850,107 |
| Supplemental disclosures of cash flow information | |||
| Noncash investing and financing activities | |||
| Accrued taxes related to net share settlement of equity awards | $— | $84,207 | $— |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.